Severity of underweight affects the development of nontuberculous mycobacterial pulmonary disease; a nationwide

Ji Young Kang1, Kyungdo Han2, Mee Kyoung Kim3

  • 1Division of Pulmonology, Department of Internal Medicine, Cheju Halla General Hospital, Jeju, 63127, South Korea.

Scientific Reports
|October 13, 2022
PubMed

Insights

The risk of developing non-tuberculous mycobacterial pulmonary disease (NTM-PD) increases with the severity of underweight. Severe underweight significantly elevates NTM-PD risk, particularly in younger males.

Area of Science:

  • Pulmonary Medicine
  • Infectious Diseases
  • Nutritional Science

Background:

  • A known association exists between underweight and non-tuberculous mycobacterial pulmonary disease (NTM-PD).
  • Previous studies broadly defined underweight using a body mass index (BMI) < 18.5 kg/m².
  • The impact of varying underweight severity on NTM-PD risk requires further definition.

Purpose of the Study:

  • To investigate the relationship between the severity of underweight and the risk of developing NTM-PD.
  • To quantify the increased risk of NTM-PD across different categories of underweight.
  • To identify demographic factors that may modify the risk associated with severe underweight.

Main Methods:

  • Analysis of health data from 4,332,529 individuals with follow-up until December 2017.
  • Categorization of underweight into mild (17.00-18.49 kg/m²), moderate (16.00-16.99 kg/m²), and severe (< 16.00 kg/m²) BMI groups.
  • Utilized Cox proportional-hazards analyses to calculate hazard ratios for NTM-PD, referencing a normal BMI range (18.50-22.99 kg/m²).

Main Results:

  • Over a median follow-up of 5.6 years, 6,223 participants developed NTM-PD.
  • A significant, proportional increase in NTM-PD risk was observed with increasing underweight severity.
  • Multivariate adjusted hazard ratios for mild, moderate, and severe underweight were 2.34, 3.50, and 4.35, respectively.

Conclusions:

  • NTM-PD risk escalates proportionally with the severity of underweight.
  • Severe underweight is a significant risk factor for NTM-PD.
  • Younger age (< 65 years) and male sex were found to exacerbate the risk of NTM-PD in individuals with severe underweight.

Related Concept Videos

Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
297
Pulmonary Tuberculosis IV01:26

Pulmonary Tuberculosis IV

Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
188
Pulmonary Tuberculosis III01:31

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
412
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
305
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
225
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
2.6K